Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.48% | 39.86% | 8.82% | -105.99% | -2,846.93% |
| Total Depreciation and Amortization | -5.37% | 33.94% | 113.00% | 45.79% | 9.26% |
| Total Amortization of Deferred Charges | 564.38% | 683.45% | -- | -- | -- |
| Total Other Non-Cash Items | -34.28% | -43.68% | -49.47% | -16.41% | 118.89% |
| Change in Net Operating Assets | -8.04% | 16.39% | 33.26% | 33.26% | 33.26% |
| Cash from Operations | 63.91% | 45.56% | 24.15% | -17.83% | -88.20% |
| Capital Expenditure | 35.69% | 45.01% | 50.27% | 46.50% | 42.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -78.58% | 13.30% | 236.72% | 70.67% | -0.53% |
| Cash from Investing | -93.50% | 70.89% | 4,751.46% | 273.81% | 33.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -36.08% | -27.77% | -19.13% | -17.04% | -14.73% |
| Issuance of Common Stock | -85.59% | -49.70% | 18.97% | -30.77% | -45.05% |
| Repurchase of Common Stock | -- | 80.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.53% | -86.10% | -446.75% | -664.81% | -1,206.45% |
| Cash from Financing | -38.53% | -47.07% | -56.54% | -73.70% | -99.97% |
| Foreign Exchange rate Adjustments | -21.92% | 84.42% | 50.24% | 109.26% | -43.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -267.24% | 201.27% | 219.11% | 344.39% | -45.34% |